Julie L Anderson
CIK 1458896 · View on SEC EDGAR ↗
First SEC filing: March 23, 2009 · Latest: March 23, 2009
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 25, 2021 | TCBIO | P | 4,000 | $60.41 | $241,640 | 70,129 Direct | +6.05% | Acquired | -65.8% (price as of 2026-08-21) |
| Oct. 28, 2015 | TCBIO | S | 917 | $55.06 | $50,490 | 23,757 Direct | -3.72% | Disposed | -62.5% (price as of 2026-08-21) |
| Feb. 9, 2009 | TCBIO | S | 3,500 | $12.22 | $42,770 | 18,093 Direct | -16.21% | Disposed | 69.1% (price as of 2026-08-21) |
| May 30, 2008 | TCBIO | S | 3,500 | $18.25 | $63,875 | 9,686 Direct | -26.54% | Disposed | 13.2% (price as of 2026-08-21) |
| Nov. 1, 2005 | TCBIO | S | 5,100 | $21.10 | $107,610 | 0 Direct | -100.00% | Disposed | -2.1% (price as of 2026-08-21) |
| Oct. 28, 2005 | TCBIO | S | 2,800 | $21.79 | $61,012 | 0 Direct | -100.00% | Disposed | -5.2% (price as of 2026-08-21) |
| Oct. 28, 2005 | TCBIO | S | 100 | $21.77 | $2,177 | 2,800 Direct | -3.45% | Disposed | -5.1% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 11, 2021 | TCBIO | Common Stock | Common Stock (973) | $0.00 | March 15, 2021 | 973 | Disposed |
| Feb. 12, 2020 | TCBIO | Common Stock | Common Stock (2,657) | $0.00 | Dec. 31, 2019 | 2,657 | Disposed |
| Oct. 28, 2015 | TCBIO | Stock Appreciation Rights | Common Stock (2,145) | $22.65 | April 24, 2016 | 2,145 | Disposed |
| Feb. 9, 2009 | TCBIO | Common Stock Purchase Option | Common Stock (3,500) | $6.25 | Feb. 16, 2009 | 3,500 | Disposed |
| May 30, 2008 | TCBIO | Common Stock Purchase Option | Common Stock (3,500) | $6.25 | Feb. 16, 2009 | 3,500 | Disposed |
| April 24, 2006 | TCBIO | Stock Appreciation Rights | Common Stock (6,826) | $22.65 | April 24, 2016 | 6,826 | Acquired |
| Nov. 1, 2005 | TCBIO | Common Stock Purchase Option | Common Stock (5,100) | $6.25 | Feb. 16, 2009 | 5,100 | Disposed |
| Oct. 28, 2005 | TCBIO | Common Stock Purchase Option | Common Stock (2,800) | $6.25 | Feb. 16, 2009 | 2,800 | Disposed |
| Oct. 28, 2005 | TCBIO | Common Stock Purchase Option | Common Stock (100) | $6.25 | Feb. 16, 2009 | 100 | Disposed |
| Dec. 16, 2003 | TCBIO | Common Stock Purchase Option | Common Stock (8,500) | $13.95 | Dec. 16, 2013 | 8,500 | Acquired |
| March 18, 2003 | TCBIO | Common Stock Purchase Option | Common Stock (10,000) | $7.25 | March 18, 2013 | 10,000 | Acquired |
| April 16, 2002 | TCBIO | Common Stock Purchase Option | Common Stock (5,000) | $7.25 | April 16, 2012 | 5,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| March 23, 2009 | TCBIO | Common Stock Purchase Option→ Common Stock (15,000) | 15,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $512,500 | — | $502,471 | — | — | — | $29,915 | $1,553,286 |
| 2020 | $510,417 | — | $747,272 | — | $14,453 | — | $56,302 | $1,594,319 |
| 2018 | $472,500 | — | — | — | — | — | $25,385 | $1,464,836 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.